Literature DB >> 11997430

Quality of life and psychological functioning of icd patients.

Samuel F Sears1, Jamie B Conti.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11997430      PMCID： PMC1767118          DOI： 10.1136/heart.87.5.488

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

1.  Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias.

Authors:  J H Herbst; M Goodman; S Feldstein; J M Reilly
Journal:  Pacing Clin Electrophysiol       Date:  1999-06       Impact factor: 1.976

2.  Changes in health status and quality of life and the impact of uncertainty in patients who survive life-threatening arrhythmias.

Authors:  D L Carroll; G A Hamilton; B A McGovern
Journal:  Heart Lung       Date:  1999 Jul-Aug       Impact factor: 2.210

3.  Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review.

Authors:  S F Sears; J F Todaro; T S Lewis; W Sotile; J B Conti
Journal:  Clin Cardiol       Date:  1999-07       Impact factor: 2.882

4.  Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators.

Authors:  C Herrmann; F von zur Mühen; A Schaumann; U Buss; S Kemper; C Wantzen; B D Gonska
Journal:  Pacing Clin Electrophysiol       Date:  1997-01       Impact factor: 1.976

5.  Quality-of-life in patients receiving implantable cardioverter defibrillators at or before age 40.

Authors:  A M Dubin; W P Batsford; R J Lewis; L E Rosenfeld
Journal:  Pacing Clin Electrophysiol       Date:  1996-11       Impact factor: 1.976

6.  Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients?

Authors:  P Pauli; G Wiedemann; W Dengler; G Blaumann-Benninghoff; V Kühlkamp
Journal:  Psychosom Med       Date:  1999 Jan-Feb       Impact factor: 4.312

7.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.

Authors:  S C Credner; T Klingenheben; O Mauss; C Sticherling; S H Hohnloser
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

8.  The quality of life of patients with life-threatening arrhythmias.

Authors:  W J Arteaga; J R Windle
Journal:  Arch Intern Med       Date:  1995-10-23

9.  Reemployment following implantation of the automatic cardioverter defibrillator.

Authors:  K R Kalbfleisch; M H Lehmann; R T Steinman; K Jackson; K Axtell; C D Schuger; P J Tchou
Journal:  Am J Cardiol       Date:  1989-07-15       Impact factor: 2.778

10.  The impact of the implantable cardioverter defibrillator on quality-of-life.

Authors:  C D May; P R Smith; C J Murdock; M J Davis
Journal:  Pacing Clin Electrophysiol       Date:  1995-07       Impact factor: 1.976
View more
  56 in total

Review 1.  Informed consent in cardiac resynchronization therapy: what should be said?

Authors:  Daniel B Kramer; Dan W Brock; Usha B Tedrow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-09

2.  Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.

Authors:  Patricia H Strachan; Sandra L Carroll; Sonya de Laat; Lisa Schwartz; Heather M Arthur
Journal:  J Palliat Care       Date:  2011       Impact factor: 2.250

3.  Implantable cardioverter-defibrillators for children and young adolescents: mortality benefit confirmed--what's next?

Authors:  S F Sears; J B Conti
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

4.  Evaluation of a Novel Educational Intervention to Improve Conversations About Implantable Cardioverter-Defibrillators Management in Patients with Advanced Heart Failure.

Authors:  Ian B Kwok; Harriet Mather; Karen McKendrick; Laura Gelfman; Mathew D Hutchinson; Rachel J Lampert; Hannah I Lipman; Daniel D Matlock; Keith M Swetz; Jill Kalman; Sean Pinney; R Sean Morrison; Nathan E Goldstein
Journal:  J Palliat Med       Date:  2020-06-29       Impact factor: 2.947

5.  A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial.

Authors:  Nathan E Goldstein; Jill Kalman; Jean S Kutner; Erik K Fromme; Mathew D Hutchinson; Hannah I Lipman; Daniel D Matlock; Keith M Swetz; Rachel Lampert; Omarys Herasme; R Sean Morrison
Journal:  J Pain Symptom Manage       Date:  2014-04-21       Impact factor: 3.612

Review 6.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

7.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

8.  Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.

Authors:  Manish Undavia; Nathan E Goldstein; Pilar Cohen; Kamoltip Sinthawanarong; Magdalena Singson; Divaya Bhutani; Tracey Munson; Joseph Anthony Gomes; Avi Fischer; Davendra Mehta
Journal:  Pacing Clin Electrophysiol       Date:  2008-11       Impact factor: 1.976

Review 9.  Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood.

Authors:  Gregory Webster; Charles I Berul
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

10.  Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life.

Authors:  Susanne S Pedersen; Viola Spek; Dominic A M J Theuns; Marco Alings; Pepijn van der Voort; Luc Jordaens; Pim Cuijpers; Johan Denollet; Krista C van den Broek
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.